Funding for this research was provided by:
Department of Health | National Health and Medical Research Council (APP1091593, APP1155224)
Received: 21 October 2019
Revised: 23 March 2020
Accepted: 14 April 2020
First Online: 4 May 2020
Conflict of interest
: I.E.S serves on the editorial boards of <i>Neurology</i>® and <i>Epileptic Disorders</i>; may accrue future revenue on a pending patent re: Therapeutic compound; has received speaker honoraria from Athena Diagnostics, UCB, GSK, Eisai, and Transgenomics; has received scientific advisory board honoraria from Nutricia, UCB, and GSK; and receives/has received research support from the NHMRC, ARC, NIH, Health Research Council of New Zealand, March of Dimes, CURE, US Department of Defense, and the Perpetual Charitable Trustees. The remaining authors declare no conflict of interest.